Recomienda este artículo a tus amigos:
Advances Against Aspergillosis II: Clinical Science, Volum 1273 - Annals of the New York Academy of Sciences K Clemons
Advances Against Aspergillosis II: Clinical Science, Volum 1273 - Annals of the New York Academy of Sciences
K Clemons
Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challenge particularly in the face of increasing antifungal resistance.
illustrations
| Medios de comunicación | Libros Paperback Book (Libro con tapa blanda y lomo encolado) |
| Publicado | 22 de febrero de 2013 |
| ISBN13 | 9781573319157 |
| Editores | John Wiley and Sons Ltd |
| Páginas | 84 |
| Dimensiones | 179 × 254 × 6 mm · 216 g |
| Editor | Clemons, Karl V. (Stanford University; Santa Clara Valley Medical Centre) |
| Editor | Perlin, David S. |
| Editor | Richardson, Malcolm D. (University of Helsinki, Finland) |